We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+24.52%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$11.9B
AUM Growth
-$101M
(-0.84%)
Cap. Flow
-$1.72B
Cap. Flow
% of AUM
-14.47%
Top 10 Holdings %
Top 10 Hldgs %
16.8%
Holding
1,692
New
482
Increased
315
Reduced
482
Closed
413
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$242M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$187M |
| 3 |
AstraZeneca
AZN
|
+$163M |
| 4 |
Lockheed Martin
LMT
|
+$162M |
| 5 |
S&P Global
SPGI
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$234M |
| 2 |
Johnson & Johnson
JNJ
|
+$185M |
| 3 |
Mercado Libre
MELI
|
+$136M |
| 4 |
Procter & Gamble
PG
|
+$128M |
| 5 |
Shopify
SHOP
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.38% |
| 2 | Healthcare | 15.54% |
| 3 | Consumer Discretionary | 12.1% |
| 4 | Industrials | 11.12% |
| 5 | Communication Services | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Repligen
RGEN
$9.35B
| $497K | ﹤0.01% |
2,594
-12,402
| -83% | -$2.26M |
|
1127
Piper Sandler
PIPR
$5.34B
| $496K | ﹤0.01% |
+19,644
| New | +$445K |
|
1128
Dropbox
DBX
$7.31B
| $494K | ﹤0.01% |
+22,262
| New | +$453K |
|
1129
Triumph Financial Inc
TFIN
$1.83B
| $478K | ﹤0.01% |
+9,836
| New | +$443K |
|
|
MNTV
1130
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $476K | ﹤0.01% |
18,632
+6,807
| +58% | +$153K |
|
|
HOLX
1131
DELISTED
Hologic
HOLX
| $475K | ﹤0.01% |
6,521
-52,600
| -89% | -$3.71M |
|
1132
Insight Enterprises
NSIT
$4.54B
| $474K | ﹤0.01% |
+6,228
| New | +$420K |
|
1133
Canadian Imperial Bank of Commerce
CM
$110B
| $470K | ﹤0.01% |
10,994
-47,438
| -81% | -$1.93M |
|
1134
American Express
AXP
$232B
| $468K | ﹤0.01% |
3,869
-44,335
| -92% | -$4.91M |
|
1135
BorgWarner
BWA
$14B
| $468K | ﹤0.01% |
+13,771
| New | +$467K |
|
1136
Liberty Energy
LBRT
$3.52B
| $466K | ﹤0.01% |
+45,156
| New | +$412K |
|
1137
Diamondrock Hospitality Co
DRH
$2.5B
| $465K | ﹤0.01% |
56,317
-305,426
| -84% | -$2.04M |
|
1138
JB Hunt Transport Services
JBHT
$25.9B
| $465K | ﹤0.01% |
3,404
-27,347
| -89% | -$3.63M |
|
|
AKTS
1139
DELISTED
Akoustis Technologies Inc
AKTS
| $464K | ﹤0.01% |
+37,969
| New | +$333K |
|
|
FIT
1140
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $464K | ﹤0.01% |
68,162
-110,447
| -62% | -$779K |
|
1141
Sonoco
SON
$5.74B
| $462K | ﹤0.01% |
7,793
-9,028
| -54% | -$507K |
|
1142
AptarGroup
ATR
$8.47B
| $461K | ﹤0.01% |
+3,367
| New | +$418K |
|
1143
Chunghwa Telecom
CHT
$32.8B
| $457K | ﹤0.01% |
11,841
-31,406
| -73% | -$1.19M |
|
1144
Codexis
CDXS
$175M
| $456K | ﹤0.01% |
+20,898
| New | +$344K |
|
1145
Apogee Enterprises
APOG
$897M
| $454K | ﹤0.01% |
14,334
-42,912
| -75% | -$1.16M |
|
|
APLS
1146
DELISTED
Apellis Pharmaceuticals
APLS
| $452K | ﹤0.01% |
+7,901
| New | +$334K |
|
1147
CNA Financial
CNA
$13.7B
| $439K | ﹤0.01% |
11,278
-19,955
| -64% | -$679K |
|
1148
Primoris Services
PRIM
$4.39B
| $438K | ﹤0.01% |
+15,854
| New | +$365K |
|
|
AMED
1149
DELISTED
Amedisys
AMED
| $435K | ﹤0.01% |
1,482
-3,744
| -72% | -$960K |
|
1150
AMERISAFE
AMSF
$517M
| $435K | ﹤0.01% |
+7,583
| New | +$438K |
|
Similar funds
VAI
Voloridge Investment Management's Q4 2020 Portfolio in Review
As of Q4 2020, Voloridge Investment Management held 1,692 positions worth $11.9B, down 0.84% from $12B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Voloridge Investment Management withdrew a net $1.72B in Q4 2020, closing 413 positions and reducing 482 holdings. Its most notable exit was Wells Fargo, an estimated $111M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in AstraZeneca worth $154M.
- Voloridge Investment Management's largest Q4 2020 buy was AstraZeneca: 1,542,881 shares worth $154M.
- Voloridge Investment Management added most to Microsoft in Q4 2020, an estimated $242M increase.
- Voloridge Investment Management's biggest Q4 2020 reduction was Citigroup, cutting an estimated $234M.
- Voloridge Investment Management fully exited Wells Fargo in Q4 2020, selling an estimated $111M.
- Voloridge Investment Management's ten largest holdings make up 17% of its $11.9B portfolio in Q4 2020.
- Voloridge Investment Management opened 482 new positions and closed 413 in Q4 2020.
- Voloridge Investment Management's portfolio value fell 0.84% quarter-over-quarter to $11.9B.
Based on Voloridge Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.